
The PROGRxN-BCa study, led by Jethro C.C. Kwong, showcases a major advancement in predicting disease progression in non–muscle-invasive bladder cancer through artificial intelligence (AI).

Your AI-Trained Oncology Knowledge Connection!

Jethro C.C. Kwong is a urology resident from the University of Toronto.